Unexpected growth-stimulatory effect of somatostatin analogue on cultured human pancreatic carcinoid cells
- 1 June 1992
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 185 (2) , 577-581
- https://doi.org/10.1016/0006-291x(92)91663-b
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Receptor‐mediated autocrine growth‐stimulatory effect of 5‐hydroxytryptamine on cultured human pancreatic carcinoid cellsJournal of Cellular Physiology, 1992
- Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growthGastroenterology, 1991
- Novel Therapy for the Treatment of Human CarcinoidAnnals of Surgery, 1991
- The Effects of High Extracellular Ca2+and Mg2+Concentrations on the Levels of Inositol 1,3,4,5-Tetrakisphosphate in Bovine Parathyroid Cells*Endocrinology, 1989
- Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201–995Journal of Molecular Medicine, 1988
- Clinical evaluation of SMS 201-995Acta Endocrinologica, 1987
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- Modulation of cyclic AMP action in the dog thyroid by its agonist and antagonist Sp- and Rp-adenosine 3′,5′-monophosphorothioateBiochemical Journal, 1986
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Convenient elimination of trichloroacetic acid prior to radioimmunoassay of cyclic nucleotidesAnalytical Biochemistry, 1977